CVVIF yields 31.45% · JNJ yields 2.13%● Live data
📍 CVVIF pulled ahead of the other in Year 1
Combined, CVVIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CVVIF + JNJ for your $10,000?
Sociedad Comercial del Plata S.A. operates in construction, energy, transportation, and real estate sectors in Argentina and internationally. The company operates through Construction, Oil, Agribusiness, and Entertainment segments. It provides construction materials, such as bricks, tiles, floors and coatings, ceramics, porcelain tiles, and glasses for the construction industry. The company also engages in the development, exploration, and production of hydrocarbons, as well as trunk transportation of gas. In addition, the company offers omega grains; offers rail freight services for transporting grains from the humid pampas to the port; and invests in own securities, real estate development projects, and forestry. Further, it processes crude oil; markets fuels, lubricants, greases, and asphalt; and offers fuel storage and dock services. Additionally, the company manufactures frozen pre-fried potatoes; and operates amusement parks, theatres, and water parks. Sociedad Comercial del Plata S.A. was incorporated in 1927 and is based in Buenos Aires, Argentina.
Full CVVIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.